Sinovac Biotech

Sinovac Biotech Ltd. (Chinese: 北京科兴生物制品有限公司, NASDAQ: SVA) is a biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. The company is based in Beijing, China.

Sinovac Biotech
Founded1999 (1999)
Headquarters
Beijing
,
China
Websitehttp://www.sinovac.com/
Sinovac Biotech
Simplified Chinese北京科兴生物制品有限公司
Traditional Chinese北京科興生物製品有限公司

Sinovac's commercialized vaccines include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu (influenza), Panflu (H5N1) and PANFLU.1 (H1N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine.[1]

Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.

COVID-19 Vaccine development
See also: COVID-19 vaccine

In mid-April 2020, China approved a clinical trial for a candidate COVID-19 vaccine developed by Sinovac.[2] The vaccine, called CoronaVac, is a chemically-inactivated whole virus vaccine for COVID-19.[3]

In late July 2020, Sinovac began conducting Phase III vaccine trials in Brazil in collaboration with Butantan Institute on 9,000 volunteers, all health professionals, in six Brazilian states.[4] In early August 2020, Sinovac began conducting additional Phase III vaccine trials in Bangladesh with the International Centre for Diarrhoeal Disease Research involving 4,200 volunteers and in Indonesia with Bio Farma in West Java involving 1,600 volunteers.[5][6]

See also

References
  1. Google Finance, url=https://www.google.com/finance?q=Sinovac
  2. Zhang Zhihao (15 April 2020). "Three COVID-19 vaccines approved for clinical trials". China Daily. Retrieved 23 April 2020.
  3. Nidhi Parekh (22 July 2020). "CoronaVac: A COVID-19 Vaccine Made From Inactivated SARS-CoV-2 Virus". Retrieved 25 July 2020.
  4. Savarese, Mauricio (21 July 2020). "New coronavirus vaccine trials start in Brazil". Associated Press. Retrieved 15 August 2020.
  5. "Bangladesh to host late-stage trial of China's Sinovac COVID-19 vaccine". Reuters. 20 July 2020. Retrieved 15 August 2020.
  6. "Indonesia eyes production of 250 million doses a year of coronavirus vaccine". Reuters. 4 August 2020. Retrieved 15 August 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.